Lomerizine (KB‐2796), a New Antimigraine Drug
- 29 September 1995
- journal article
- Published by Wiley in CNS Drug Reviews
- Vol. 1 (2) , 204-226
- https://doi.org/10.1111/j.1527-3458.1995.tb00284.x
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Effect of Vitamin E on Keratinocyte-Modulation Induced by LauroylsarcosineThe Japanese Journal of Pharmacology, 1995
- The effects of a novel Ca2+ channel blocker, KB-2796, on 5-HT-induced responses.Folia Pharmacologica Japonica, 1994
- Involvement of α1-but Not α2-Adrenergic Systems in the Antagonizing Effect of Paeoniflorin on Scopolamine-Induced Deficit in Radial Maze Performance in RatsThe Japanese Journal of Pharmacology, 1993
- Neurochemical Investigation on the Effects of a New Diphenylpiperazine Calcium Antagonist, KB-2796, on the Central Dopaminergic System of Rats.The Japanese Journal of Pharmacology, 1992
- Selective Effect of KB-2796, a New Calcium Entry Blocker, on Cerebral CirculationJournal of Cardiovascular Pharmacology, 1990
- KB-2796, A New Ca2+AntagonistCardiovascular Drug Reviews, 1990
- Calcium Antagonists in Migraine and VertigoEuropean Neurology, 1990
- Treating migraine.BMJ, 1989
- Benzylpiperazine derivatives. IV. Syntheses and cerebral vasodilating activities of 1-benzyl-4-diphenylmethylpiperazine derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1987
- Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral MicrodialysisJournal of Neurochemistry, 1984